SCANPHARM A/S: Financial statements 2019
CVR: 16279099
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 17,829,889 and a net result of DKK -3,977,723 compared with DKK -2,876,360 the year before. That is a decrease of 8.9% compared with the year before. Equity in the 2019 report amounted to DKK 5,889,286. The solvency ratio was 16.7%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 17,829,889
- Profit/Loss
- DKK -3,977,723
- Equity
- DKK 5,889,286
- Total Assets
- DKK 35,162,043
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 17.8 mio. | -4 mio. | 5.9 mio. | 42 |
| 2018 | - | 19.6 mio. | -2.9 mio. | 9.9 mio. | 46 |
| 2017 | - | 19.1 mio. | -228 t. | 12.7 mio. | 43 |
| 2016 | - | 19.6 mio. | 1.3 mio. | 13 mio. | 42 |
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
SCANPHARM A/S has published its annual report for 2018. Gross profit came to DKK 19,563,917, and the net result was DKK -2,876,360.
As of March 1, 2019, CHLOPETHAN A/S is registered as an owner of SCANPHARM A/S with an ownership share of 90%.
As of February 28, 2019, Andreas Bjørn Jensen is registered as adm. dir. of SCANPHARM A/S.
As of February 28, 2019, Rolf Eckersberg has stepped down as director of SCANPHARM A/S.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.